The DOI matches its Crossref record.
Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions
Abstract
To determine the role of CD154-CD40 interactions in the B cell overactivity exhibited by patients with active systemic lupus erythematosus (SLE), CD19+ peripheral B cells were examined before and after treatment with humanized anti-CD154 mAb (BG9588, 5c8). Before treatment, SLE patients manifested activated B cells that expressed CD154, CD69, CD38, CD5, and CD27. Cells expressing CD38, CD5, or CD27 disappeared from the periphery during treatment with anti-CD154 mAb, and cells expressing CD69 and CD154 disappeared from the periphery during the post-treatment period. Before treatment, active-SLE patients had circulating CD38bright Ig-secreting cells that were not found in normal individuals. Disappearance of this plasma cell subset during treatment was associated with decreases in anti–double-stranded DNA (anti-dsDNA) Ab levels, proteinuria, and SLE disease activity index. Consistent with this finding, peripheral B cells cultured in vitro spontaneously proliferated and secreted Ig in a manner that was inhibited by anti-CD154 mAb. Finally, the CD38+/++IgD+, CD38+++, and CD38+IgD– B cell subsets present in the peripheral blood also disappeared following treatment with humanized anti-CD154. Together, these results indicate that patients with active lupus nephritis exhibit abnormalities in the peripheral B cell compartment that are consistent with intensive germinal center activity, are driven via CD154-CD40 interactions, and may reflect or contribute to the propensity of these patients to produce autoantibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 90
- Grammer, 2001, Molecular Pathology of Autoimmune Diseases., 2, 282
- 10.1038/ni0901-764 · DOI · Paper page
- 10.1002/art.10287 · DOI
- 10.1002/1529-0131(200112)44:12<2715::AID-ART458>3.0.CO;2-L · doi:10.1002/1529-0131(200112)44:12<2715::aid-art458>3.0.co;2-l
- Grammer, 1999, J. Immunol., 163, 4150, 10.4049/jimmunol.163.8.4150 · DOI
- 10.1073/pnas.032665099 · DOI
- Miyashita, 1997, J. Immunol., 158, 4620, 10.4049/jimmunol.158.10.4620 · DOI
- 10.1002/eji.200323357 · doi:10.1002/eji.200323357
- 10.1046/j.1365-2567.2000.00098.x · DOI
- 10.1016/0008-8749(92)90111-2 · doi:10.1016/0008-8749(92)90111-2
- Grammer, 2000, Adv. Immunol., 76, 61, 10.1016/S0065-2776(01)76019-1 · DOI
- Dono, 2000, J. Immunol., 164, 5596, 10.4049/jimmunol.164.11.5596 · DOI
- 10.1136/jcp.53.5.395 · doi:10.1136/jcp.53.5.395
- 10.1111/j.1600-065X.1997.tb00963.x · DOI · Paper page
- 10.1007/BF02786360 · DOI
- 10.1046/j.1365-3083.1997.d01-417.x · doi:10.1046/j.1365-3083.1997.d01-417.x
- 10.1002/eji.1830260911 · DOI
- 10.1182/blood.V99.6.2154 · DOI · Paper page
- 10.1002/eji.1830260808 · doi:10.1002/eji.1830260808
- 10.1084/jem.180.1.329 · DOI · Paper page
- 10.1046/j.1365-2141.1996.300835.x · DOI
- 10.1046/j.1365-2249.1998.00533.x · doi:10.1046/j.1365-2249.1998.00533.x
- 10.1002/1529-0131(199912)42:12<2593::AID-ANR12>3.0.CO;2-G · doi:10.1002/1529-0131(199912)42:12<2593::aid-anr12>3.0.co;2-g
- Arce, 2001, J. Immunol., 167, 2361, 10.4049/jimmunol.167.4.2361 · DOI · Paper page
- 10.1191/096120301701548517 · DOI
- Odendahl, 2000, J. Immunol., 165, 5970, 10.4049/jimmunol.165.10.5970 · DOI · Paper page
- 10.1002/art.10949 · DOI · Paper page
- 10.1111/j.1365-3083.1995.tb03673.x · doi:10.1111/j.1365-3083.1995.tb03673.x
- Han, 1995, J. Immunol., 155, 556, 10.4049/jimmunol.155.2.556 · DOI · Paper page
- 10.1002/1521-4141(200009)30:9<2548::AID-IMMU2548>3.0.CO;2-H · DOI
- Luzina, 2001, J. Leukoc. Biol., 70, 578, 10.1189/jlb.70.4.578 · DOI · Paper page
- Vora, 1998, J. Immunol., 160, 728, 10.4049/jimmunol.160.2.728 · DOI
- 10.1126/science.281.5373.96 · DOI · Paper page
- 10.1084/jem.180.1.141 · DOI · Paper page
- 10.1126/science.7537388 · DOI · Paper page
- 10.1002/1521-4141(200103)31:3<752::AID-IMMU752>3.0.CO;2-9 · doi:10.1002/1521-4141(200103)31:3<752::aid-immu752>3.0.co;2-9
- 10.1002/1521-4141(200105)31:5<1340::AID-IMMU1340>3.0.CO;2-H · DOI
- 10.1002/art.10273 · DOI · Paper page
- 10.1002/art.10856 · DOI · Paper page
- 10.1002/art.1780251101 · DOI · Paper page
- 10.1016/S0161-5890(01)00036-0 · doi:10.1016/s0161-5890(01)00036-0
- 10.1172/JCI3113 · DOI
- 10.1006/clim.1999.4740 · DOI
- Jacobi, 2000, Autoimmunity., 33, 61, 10.3109/08916930108994110 · doi:10.3109/08916930108994110
- 10.1186/ar329 · doi:10.1186/ar329
- 10.1002/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H · DOI · Paper page
- 10.1172/JCI114418 · doi:10.1172/jci114418
- Facchetti, 1995, J. Immunol., 154, 6624, 10.4049/jimmunol.154.12.6624 · DOI
- 10.1093/intimm/12.6.767 · doi:10.1093/intimm/12.6.767
- 10.1006/clim.2001.5049 · DOI
- 10.1172/JCI3409 · DOI · Paper page
- 10.1073/pnas.98.3.1166 · DOI · Paper page
- Splawski, 1993, Res. Immunol., 145, 226, 10.1016/S0923-2494(94)80189-4 · doi:10.1016/s0923-2494(94)80189-4
- Nishioka, 1994, J. Immunol., 153, 1027, 10.4049/jimmunol.153.3.1027 · doi:10.4049/jimmunol.153.3.1027
- McCarty, 1982, J. Rheumatol., 9, 691
- 10.1097/00007611-198911000-00021 · doi:10.1097/00007611-198911000-00021
- Ginsburg, 1978, J. Immunol., 120, 33, 10.4049/jimmunol.120.1.33 · doi:10.4049/jimmunol.120.1.33
- Jelinek, 1983, J. Immunol., 130, 2597, 10.4049/jimmunol.130.6.2597 · doi:10.4049/jimmunol.130.6.2597
- Vernino, 1992, J. Immunol., 148, 404, 10.4049/jimmunol.148.2.404 · DOI
- Grammer, 1995, J. Immunol., 154, 4996, 10.4049/jimmunol.154.10.4996 · DOI · Paper page
- 10.1111/j.1749-6632.1997.tb52088.x · DOI
- 10.1046/j.1365-2249.2001.01518.x · doi:10.1046/j.1365-2249.2001.01518.x
- 10.1016/S1567-5769(00)00020-5 · DOI
- Lettesjo, 2000, J. Immunol., 165, 4095, 10.4049/jimmunol.165.7.4095 · doi:10.4049/jimmunol.165.7.4095
- 10.1002/1521-4141(200112)31:12<3484::AID-IMMU3484>3.0.CO;2-5 · doi:10.1002/1521-4141(200112)31:12<3484::aid-immu3484>3.0.co;2-5
- Higuchi, 2002, J. Immunol., 168, 9, 10.4049/jimmunol.168.1.9 · DOI · Paper page
- Krzysiek, 2000, Blood., 96, 2338, 10.1182/blood.V96.7.2338 · DOI · Paper page
- 10.1182/blood.V98.4.1047 · doi:10.1182/blood.v98.4.1047
- 10.1080/09537100020031207 · DOI · Paper page
- 10.1016/S0006-2952(00)00452-4 · DOI
- Slupsky, 1998, Thromb. Haemost., 80, 1008, 10.1055/s-0037-1615402 · DOI · Paper page
- 10.1038/35393 · DOI · Paper page
- 10.1161/hh2401.101272 · DOI · Paper page
- Bruemmer, 2001, Am. J. Cardiol., 87, 21, 10.1016/S0002-9149(00)01266-2 · DOI
- 10.1007/s004280000239 · DOI
- 10.1002/1521-4141(200010)30:10<2864::AID-IMMU2864>3.0.CO;2-W · doi:10.1002/1521-4141(200010)30:10<2864::aid-immu2864>3.0.co;2-w
- 10.1046/j.1365-2567.2000.00061.x · doi:10.1046/j.1365-2567.2000.00061.x
- 10.1006/cimm.1999.1583 · DOI
- 10.1097/00007890-199908150-00016 · DOI
- 10.1084/jem.189.5.843 · DOI
- Slupsky, 1998, Thromb. Haemost., 80, 1008, 10.1055/s-0037-1615402 · DOI · Paper page
- Zhou, 1998, Thromb. Haemost., 79, 1025, 10.1055/s-0037-1615114 · doi:10.1055/s-0037-1615114
- Dechanet, 1997, J. Immunol., 159, 5640, 10.4049/jimmunol.159.11.5640 · DOI
- Miller, 1998, J. Leukoc. Biol., 63, 373, 10.1002/jlb.63.3.373 · DOI · Paper page
- 10.1073/pnas.94.5.1931 · DOI · Paper page
- 10.1084/jem.184.1.173 · DOI
- 10.1084/jem.182.1.33 · DOI · Paper page
- 10.1073/pnas.92.10.4342 · DOI · Paper page
- 10.1093/rheumatology/28.2.95 · doi:10.1093/rheumatology/28.2.95
- 10.1002/art.10681 · DOI · Paper page
Cited by
Simpson, N., Gatenby, P. A., Wilson, A., Malik, S., Fulcher, D. A., Tangye, S. G., Manku, H., Vyse, T. J., Roncador, G., Huttley, G. A., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.25032 · Cited by 684
T Follicular Helper (TFH) Cells in Normal and Dysregulated Immune Responses
King, C., Tangye, S. G., & Mackay, C. R. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090344 · Cited by 632
Follicular B helper T cells in antibody responses and autoimmunity
Vinuesa, C. G., Tangye, S. G., Moser, B., & Mackay, C. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1714 · Cited by 624
Wei, C., Anolik, J., Cappione, A., Zheng, B., Pugh-Bernard, A., Brooks, J., Lee, E.-H., Milner, E. C. B., & Sanz, I. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6624 · Cited by 604
Immunopathogenic mechanisms of systemic autoimmune disease
Wahren-Herlenius, M., & Dörner, T. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60954-x · Cited by 593
Follicular helper T cells are required for systemic autoimmunity
Linterman, M. A., Rigby, R. J., Wong, R. K., Yu, D., Brink, R., Cannons, J. L., Schwartzberg, P. L., Cook, M. C., Walters, G. D., & Vinuesa, C. G. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081886 · Cited by 587
Importance of Cellular Microenvironment and Circulatory Dynamics in B Cell Immunotherapy
Gong, Q., Ou, Q., Ye, S., Lee, W. P., Cornelius, J., Diehl, L., Lin, W. Y., Hu, Z., Lu, Y., Chen, Y., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.817 · Cited by 543
Dysregulation of germinal centres in autoimmune disease
Vinuesa, C. G., Sanz, I., & Cook, M. C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2637 · Cited by 464
Regulation of Humoral Immunity by Complement
Carroll, M. C., & Isenman, D. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.002 · Cited by 387
Follicular helper T cells in immunity and systemic autoimmunity
Craft, J. E. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.58 · Cited by 375
B CELL IMMUNOBIOLOGY IN DISEASE: Evolving Concepts from the Clinic
Martin, F., & Chan, A. C. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090517 · Cited by 369
The pathogenesis of systemic lupus erythematosus—an update
Choi, J., Kim, S. T., & Craft, J. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.10.004 · Cited by 360
Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond
Karnell, J. L., Rieder, S. A., Ettinger, R., & Kolbeck, R. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.005 · Cited by 334
Choi, J., Ho, J. H., Pasoto, S. G., Bunin, V., Kim, S. T., Carrasco, S., Borba, E. F., Gonçalves, C. R., Costa, P. R., Kallas, E. G., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39020 · Cited by 326
Dörner, T., Kaufmann, J., Wegener, W. A., Teoh, N., Goldenberg, D. M., & Burmester, G. R. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1942 · Cited by 306
Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint
Tang, T., Cheng, X., Truong, B., Sun, L., Yang, X., & Wang, H. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107709 · Cited by 271
CD40 and autoimmunity: The dark side of a great activator
Peters, A. L., Stunz, L. L., & Bishop, G. A. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.012 · Cited by 270
Regulatory T cells in systemic lupus erythematosus
Ohl, K., & Tenbrock, K. (2015) · European Journal of Immunology · doi:10.1002/eji.201344280 · Cited by 262
Almerighi, C., Sinistro, A., Cavazza, A., Ciaprini, C., Rocchi, G., & Bergamini, A. (2009) · Cytokine · doi:10.1016/j.cyto.2008.12.009 · Cited by 221
Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients
Sidiropoulos, P. I., & Boumpas, D. T. (2004) · Lupus · doi:10.1191/0961203304lu1032oa · Cited by 178
Jacobi, A. M., Goldenberg, D. M., Hiepe, F., Radbruch, A., Burmester, G. R., & Dörner, T. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.075762 · Cited by 127
The impact of senescence-associated T cells on immunosenescence and age-related disorders
Fukushima, Y., Minato, N., & Hattori, M. (2018) · Inflammation and Regeneration · doi:10.1186/s41232-018-0082-9 · Cited by 118
Tahir, S., Fukushima, Y., Sakamoto, K., Sato, K., Fujita, H., Inoue, J., Uede, T., Hamazaki, Y., Hattori, M., & Minato, N. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500319 · Cited by 113
Metadata
- Authors
- Grammer, A. C., Slota, R., Fischer, R., Gur, H., Girschick, H., Yarboro, C., Illei, G. G., & Lipsky, P. E.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-11-15
- Volume
- 112
- Issue
- 10
- Pages
- 1506-1520
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4230977854
- Cited by
- 228
- References
- 0
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.